Company intelligence / Profile preview

Hooke Bio

Limerick, Ireland

Ownership: Private
Employees: ~4
Development stage: Other

Overview

Hooke Bio is developing and commercializing a microfluidic high-throughput screening platform to accelerate drug discovery by enabling fast, cost-effective biochemical and cellular assays, primarily for 3D cell cultures such as spheroids, organoids, and tumouroids. No direct therapeutic or clinical results (as it is an R&D tools/platform provider).

Modalities: DeviceHigh throughput screening platform
Industry: Drug Discovery Services

Partnerships

Centre for Advanced Photonics and Process Analysis (CAPPA)NUI GalwayRelevium MedicalUniversity of Galway

Beyond the preview

Go deeper on Hooke Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hooke Bio.

Explore the full profile